Fakultni nemocnice Brno

Brno-Bohunice 62500

1 studies enrolling now · 4 studies all time

What they study most

Bipolar I Disorder, Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma, Small Lymphocytic Lymphoma

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex — Completed